An effective S-1 lets Medline access public capital and creates potential dilution and new trading liquidity
The follow-up risk is whether more supply becomes eligible. The filing also points to possible overhang outside the current pool. Next trigger: Prospectus/prospectus supplement for offering size and use of proceeds
Current shares plus potential supply
Potential supply was not disclosed or mechanically calculable, so share overhang is not calculated.
Share counts are filing-stated unless noted and may differ after splits, conversions, or later offerings.
High share overhang may create selling pressure. Monitor warrant exercise and note conversion activity.
SEC filing text preserved from the raw item store.
### EFFECT
Notice of Effectiveness
UNITED STATES |
SECURITIES AND EXCHANGE COMMISSION |
Washington, D.C. 20549 |
Notice of Effectiveness |
Effectiveness Date: |
May 21,
2026 4:05 P.M.
|
Form: |
S-1 |
CIK: |
0002046386 |
Company Name: |
Medline Inc. |
File Number: |
333-296044 |
|
### EFFECT
X0101
EFFECT
33
LIVE
2026-05-21
16:05:00
S-1
0002046386
Medline Inc.
333-296044
| Form | EFFECT |
|---|---|
| Normalized event type | Dilution Risk |